{"id":"W4412124270","doi":"10.1093/crocol/otaf031","title":"Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naïve Patients With Early or Late Crohn’s Disease: Results From the EVOLVE Expansion Study","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thermo Fisher Scientific (Canada); St. Paul's Hospital","funders":"Takeda Foundation","keywords":"Vedolizumab; Ustekinumab; Crohn's disease; Medicine; Disease; Dermatology; Internal medicine; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006273462,0.0002569415,0.0008285863,0.0004786612,0.000219607,0.000865738,0.0003555864,0.0003966854,0.0009383958],"category_scores_gemma":[0.006593803,0.0001480592,0.0009635322,0.0006230322,0.0003952593,0.0006265452,0.000556188,0.0005053498,0.0001395517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006560229,"about_ca_system_score_gemma":0.0005172742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008087017,"about_ca_topic_score_gemma":0.001392151,"domain_scores_codex":[0.9948239,0.003225158,0.0005018436,0.0004729251,0.0008301476,0.0001459752],"domain_scores_gemma":[0.9891774,0.003570447,0.005156908,0.0005140877,0.0007656949,0.0008155297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07515757,0.002263109,0.8583609,0.0008288257,0.003051679,0.0001403119,0.0002780797,0.001040446,0.002487683,0.0001343555,0.0009793056,0.05527751],"study_design_scores_gemma":[0.007520572,0.01927602,0.9651806,0.0001434525,0.001605851,0.0004729439,0.0001941339,0.001299043,0.001594257,0.00007546296,0.002599128,0.00003850626],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957331,0.002683727,0.000097123,0.0000663463,0.000006458034,0.00007569828,0.000709187,0.000005340578,0.000623016],"genre_scores_gemma":[0.9975119,0.0005000808,0.0002725336,0.0001135138,0.00004423579,0.00007106928,0.001359098,0.000002547937,0.0001250521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006273462,"threshold_uncertainty_score":0.03317761,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01162384803834654,"score_gpt":0.2865311887779796,"score_spread":0.274907340739633,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}